These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1835583)

  • 21. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
    J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiation Oncology Clinical Trial Design: An Opportunity to Evaluate Value.
    Shah C; Ward M; Singer ME
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):674-675. PubMed ID: 31540597
    [No Abstract]   [Full Text] [Related]  

  • 23. Wanted: senior citizens for cancer treatment trials.
    Benowitz S
    J Natl Cancer Inst; 2000 Mar; 92(6):446-7. PubMed ID: 10716958
    [No Abstract]   [Full Text] [Related]  

  • 24. [Conducting a cost-effectiveness trial in oncology: justification and method].
    Lejeune C; Binquet C; Bonnetain F
    Bull Cancer; 2009 May; 96(5):603-7. PubMed ID: 19435689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer Center.
    Huber SL
    Cancer; 1993 Nov; 72(9 Suppl):2824-7. PubMed ID: 8402512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer patient care in clinical trials sponsored by the National Cancer Institute: what does it cost?
    Brown ML
    J Natl Cancer Inst; 1999 May; 91(10):818-9. PubMed ID: 10340896
    [No Abstract]   [Full Text] [Related]  

  • 27. Eastern Cooperative Oncology Group (ECOG).
    Fairclough DL; Cella DF
    J Natl Cancer Inst Monogr; 1996; (20):73-5. PubMed ID: 8750470
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project.
    Bennett CL; Stinson TJ; Vogel V; Robertson L; Leedy D; O'Brien P; Hobbs J; Sutton T; Ruckdeschel JC; Chirikos TN; Weiner RS; Ramsey MM; Wicha MS
    J Clin Oncol; 2000 Aug; 18(15):2805-10. PubMed ID: 10920127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The design of future cost-benefit studies.
    Maynard A
    Am Heart J; 1990 Mar; 119(3 Pt 2):761-5. PubMed ID: 2106769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluation of cancer therapies: more and better studies will lead to better choices in cancer care.
    Uyl-de Groot CA
    Eur J Cancer; 2006 Nov; 42(17):2862-6. PubMed ID: 17008095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health Economics Unit achievements.
    Crott R; Neymark N
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S147-50. PubMed ID: 11858982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of interventions for malignant neoplasms in Spain: systematic review and comparative analysis.
    Catalá-López F; García-Altés A; Álvarez-Martín E; Gènova-Maleras R; Morant-Ginestar C; Arana E
    Farm Hosp; 2012; 36(3):141-7. PubMed ID: 22030159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement and valuation of quality of life in economic appraisal of cancer treatment.
    Uyl-de Groot CA; Rutten FF; Bonsel GJ
    Eur J Cancer; 1994; 30A(1):111-7. PubMed ID: 8142152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How should we value lives lost to cancer?
    Ramsey SD
    J Natl Cancer Inst; 2008 Dec; 100(24):1742-3. PubMed ID: 19066279
    [No Abstract]   [Full Text] [Related]  

  • 35. Recognizing the Financial Burden of Cancer Patients in Clinical Trials.
    Nipp RD; Powell E; Chabner B; Moy B
    Oncologist; 2015 Jun; 20(6):572-5. PubMed ID: 25986245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paying for patient care in treatment research--who is responsible?
    Wittes RE
    Cancer Treat Rep; 1987 Feb; 71(2):107-13. PubMed ID: 3100033
    [No Abstract]   [Full Text] [Related]  

  • 37. The quality of economic studies of cancer pharmacogenomics: a quantitative appraisal of the evidence.
    Yang M; Patel DS; Tufail W; Issa AM
    Expert Rev Pharmacoecon Outcomes Res; 2013 Oct; 13(5):597-611. PubMed ID: 24138646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cost of clinical trials in cancer.
    Snyder RD; Burns WI
    Aust Health Rev; 1982 May; 5(2):27-8. PubMed ID: 10256885
    [No Abstract]   [Full Text] [Related]  

  • 39. Ought cancer treatments to be immune from socio-economic evaluation? An epilogue.
    Culyer AJ; Jönsson B
    Eur J Cancer; 1993; 29A Suppl 7():S31-2. PubMed ID: 8312061
    [No Abstract]   [Full Text] [Related]  

  • 40. Value of clinical trials.
    Sinks LF
    Med Pediatr Oncol; 1999 Oct; 33(4):434. PubMed ID: 10491564
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.